FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883191982> ?p ?o ?g. }

• W2883191982 endingPage "1315" @default.
• W2883191982 startingPage "1305" @default.
• W2883191982 abstract "Lysophosphatidic acid (LPA) is a bioactive lipid growth factor which is present in high levels in serum and platelets. LPA binds to its specific G-protein-coupled receptors, including LPA1 to LPA6, thereby regulating various physiological functions, including cancer growth, angiogenesis, and lymphangiogenesis. Our previous study showed that LPA promotes the expression of the lymphangiogenic factor vascular endothelial growth factor (VEGF)-C in prostate cancer (PCa) cells. Interestingly, LPA has been shown to regulate the expression of calreticulin (CRT), a multifunctional chaperone protein, but the roles of CRT in PCa progression remain unclear. Here we investigated the involvement of CRT in LPA-mediated VEGF-C expression and lymphangiogenesis in PCa. Knockdown of CRT significantly reduced LPA-induced VEGF-C expression in PC-3 cells. Moreover, LPA promoted CRT expression through LPA receptors LPA1 and LPA3, reactive oxygen species (ROS) production, and phosphorylation of eukaryotic translation initiation factor 2α (eIF2α). Tumor-xenografted mouse experiments further showed that CRT knockdown suppressed tumor growth and lymphangiogenesis. Notably, clinical evidence indicated that the LPA-producing enzyme autotaxin (ATX) is related to CRT and that CRT level is highly associated with lymphatic vessel density and VEGF-C expression. Interestingly, the pharmacological antagonist of LPA receptors significantly reduced the lymphatic vessel density in tumor and lymph node metastasis in tumor-bearing nude mice. Together, our results demonstrated that CRT is critical in PCa progression through the mediation of LPA-induced VEGF-C expression, implying that targeting the LPA signaling axis is a potential therapeutic strategy for PCa." @default.
• W2883191982 created "2018-08-03" @default.
• W2883191982 creator A5003728555 @default.
• W2883191982 creator A5017273611 @default.
• W2883191982 creator A5031928133 @default.
• W2883191982 creator A5042371488 @default.
• W2883191982 creator A5046466971 @default.
• W2883191982 creator A5059641397 @default.
• W2883191982 creator A5071351721 @default.
• W2883191982 creator A5077291181 @default.
• W2883191982 creator A5077809487 @default.
• W2883191982 creator A5081214936 @default.
• W2883191982 creator A5088985628 @default.
• W2883191982 date "2018-10-01" @default.
• W2883191982 modified "2023-10-13" @default.
• W2883191982 title "LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer" @default.
• W2883191982 cites W1489873347 @default.
• W2883191982 cites W1531820450 @default.
• W2883191982 cites W1600052472 @default.
• W2883191982 cites W1776576701 @default.
• W2883191982 cites W1968124895 @default.
• W2883191982 cites W1970482691 @default.
• W2883191982 cites W1971421921 @default.
• W2883191982 cites W1971653872 @default.
• W2883191982 cites W1974734211 @default.
• W2883191982 cites W1976841754 @default.
• W2883191982 cites W1985330772 @default.
• W2883191982 cites W1993749357 @default.
• W2883191982 cites W1994262463 @default.
• W2883191982 cites W1995223878 @default.
• W2883191982 cites W1995658890 @default.
• W2883191982 cites W1995712305 @default.
• W2883191982 cites W1996922835 @default.
• W2883191982 cites W1999466952 @default.
• W2883191982 cites W1999599951 @default.
• W2883191982 cites W2000920039 @default.
• W2883191982 cites W2004190103 @default.
• W2883191982 cites W2008691375 @default.
• W2883191982 cites W2012662402 @default.
• W2883191982 cites W2019243374 @default.
• W2883191982 cites W2024375126 @default.
• W2883191982 cites W2025133714 @default.
• W2883191982 cites W2031192254 @default.
• W2883191982 cites W2033121519 @default.
• W2883191982 cites W2034136338 @default.
• W2883191982 cites W2036677133 @default.
• W2883191982 cites W2038223157 @default.
• W2883191982 cites W2038762634 @default.
• W2883191982 cites W2044872755 @default.
• W2883191982 cites W2045563357 @default.
• W2883191982 cites W2046695461 @default.
• W2883191982 cites W2050861079 @default.
• W2883191982 cites W2057094874 @default.
• W2883191982 cites W2065582394 @default.
• W2883191982 cites W2067121396 @default.
• W2883191982 cites W2067437913 @default.
• W2883191982 cites W2068106019 @default.
• W2883191982 cites W2068492270 @default.
• W2883191982 cites W2072169154 @default.
• W2883191982 cites W2076261339 @default.
• W2883191982 cites W2080328239 @default.
• W2883191982 cites W2086603527 @default.
• W2883191982 cites W2092713092 @default.
• W2883191982 cites W2101244982 @default.
• W2883191982 cites W2112243175 @default.
• W2883191982 cites W2119391023 @default.
• W2883191982 cites W2120459320 @default.
• W2883191982 cites W2121431469 @default.
• W2883191982 cites W2128009779 @default.
• W2883191982 cites W2135913162 @default.
• W2883191982 cites W2142868586 @default.
• W2883191982 cites W2146021659 @default.
• W2883191982 cites W2150847879 @default.
• W2883191982 cites W2153609006 @default.
• W2883191982 cites W2154011324 @default.
• W2883191982 cites W2160904849 @default.
• W2883191982 cites W2162197932 @default.
• W2883191982 cites W4235927881 @default.
• W2883191982 cites W4245305755 @default.
• W2883191982 doi "https://doi.org/10.1016/j.bbalip.2018.07.005" @default.
• W2883191982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30053596" @default.
• W2883191982 hasPublicationYear "2018" @default.
• W2883191982 type Work @default.
• W2883191982 sameAs 2883191982 @default.
• W2883191982 citedByCount "17" @default.
• W2883191982 countsByYear W28831919822018 @default.
• W2883191982 countsByYear W28831919822019 @default.
• W2883191982 countsByYear W28831919822020 @default.
• W2883191982 countsByYear W28831919822021 @default.
• W2883191982 countsByYear W28831919822022 @default.
• W2883191982 countsByYear W28831919822023 @default.
• W2883191982 crossrefType "journal-article" @default.
• W2883191982 hasAuthorship W2883191982A5003728555 @default.
• W2883191982 hasAuthorship W2883191982A5017273611 @default.
• W2883191982 hasAuthorship W2883191982A5031928133 @default.
• W2883191982 hasAuthorship W2883191982A5042371488 @default.
• W2883191982 hasAuthorship W2883191982A5046466971 @default.
• W2883191982 hasAuthorship W2883191982A5059641397 @default.

• next